Kangfuxin Solution

  • Brief Infomation:
  • Kangfuxin Solution, an original variety of SINOWAY Natural Pharmaceuticals, is orally administered for blood stasis, stomachache and bleeding, gastric and duodenal ulcer, yin deficiency and pulmonary consumption, adjuvant therapy of pulmonary tuberculosis, etc., and topically applied for various traumas, such as incised wound, external injury, ulcer, fistula, burn, scald and bedsore wound to promote the regeneration of body tissues.

  • Font size: Large middle Small
  • Read: 2072
  • Kangfuxin Ye

    Kangfuxin Solution

    This product is a preparation for extracting and separating effective parts from periplaneta Americana. Clinical application: Oral use, It is indicated for blood stasis, stomachache and bleeding, stomach ulcer and duodenum ulcer; adjuvant treatment of yin deficiency and pulmonary consumption, and tuberculosis. External use: It is indicated for wound surfaces of incised wound, trauma, ulcer, fistula, burn, scald and bedsore.

    Dosage and administration: For oral use, 10 ml/time, 3 times daily, or follow the medical advice.

    For external use, soak the medical gauze with this product and apply it to the affected area, debride the infected wound before rinsing with this product, and fill or apply with gauze soaked in this product.

    Adverse reactions: The following adverse reactions are observed based on clinical data monitoring:
    Digestive system: nausea, vomiting, abdominal distension, abdominal pain, diarrhea, etc.
    Application site: redness, swelling and pain.
    Skin: rash, itching, etc.
    Others: dizziness, headache, chest tightness, palpitations, flushing, dyspnea, allergic reactions, and local numbness, anaphylactic shock, and other cases reported.

    Contraindications:1. It is contraindicated in patients allergic to this product and its ingredients.
    2. It is contraindicated in patients with asthma.
    3. It is contraindicated in pregnant.

    Warnings and Precautions: Use with caution in patients with allergic constitution.

    Reference specification: WS3-B-3674-2000 (Z)

    Approval No.: SFDA Approval No. Z53020054

    Marketing Authorization Holder: Company Name: Kunming Sinoway Pharmaceutical Co.Ltd..